PDF(Pubmed)
Abstract：
BACKGROUND: Substance use disorder (SUD) is a major health issue in Indonesia, where several barriers to treatment exist, including inaccessibility to treatment services, stigma, and criminalization of drug issues. Peer involvement and the use of telemedicine to deliver psychotherapy are promising approaches to overcome these barriers.
OBJECTIVE: This study aims (1) to describe the development of a new group psychotherapy coprovided by a health care worker and a peer and (2) to evaluate the acceptability, practicality, and preliminary outcomes of the program delivered via videoconferencing in Indonesia.
METHODS: Building upon an established relapse prevention therapy in Japan, we developed a 3-month weekly group therapy module in the Indonesian language. Adjustments were made via focus group discussions with local stakeholders in terms of substance types, understandability, inclusive language, and cultural relevance. A pilot study was conducted to test the new module provided by a peer and a psychiatrist via videoconferencing, termed tele-Indonesia Drug Addiction Relapse Prevention Program (tele-Indo-DARPP), with a pre- and postcontrolled design. We analyzed data from semistructured feedback interviews and outcome measurements, including the number of days using substances and quality of life, and compared the intervention (tele-Indo-DARPP added to treatment as usual [TAU]) and control (TAU only) arms.
RESULTS: In total, 8 people diagnosed with SUD participated in the pilot study with a mean age of 37 (SD 12.8) years. All were men, and 7 (88%) used sedatives as the primary substance. Collectively, they attended 44 of the 48 tele-Indo-DARPP sessions. A total of 3 out of 4 (75%) preferred telemedicine rather than in-person therapy. Positive acceptability and practicality were shown from qualitative feedback, in which the participants who joined the tele-Indo-DARPP reported that they liked the convenience of joining from home and that they were able to open up about personal matters, received helpful advice from peers, and received support from other participants. Providers reported that they feel the module was provider-friendly, and the session was convenient to join without diminishing rapport-building. Meanwhile, troubles with the internet connection and difficulty in comprehending some terminology in the workbook were reported. The intervention arm showed better improvements in psychological health and anxiety symptoms.
CONCLUSIONS: Group psychotherapy via videoconferencing coprovided by health care workers and peers was acceptable and practical for participants with SUD and service providers in this study. A large-scale study is warranted to examine the effectiveness of the newly developed module in Indonesia.
OBJECTIVE: This study aims (1) to describe the development of a new group psychotherapy coprovided by a health care worker and a peer and (2) to evaluate the acceptability, practicality, and preliminary outcomes of the program delivered via videoconferencing in Indonesia.
METHODS: Building upon an established relapse prevention therapy in Japan, we developed a 3-month weekly group therapy module in the Indonesian language. Adjustments were made via focus group discussions with local stakeholders in terms of substance types, understandability, inclusive language, and cultural relevance. A pilot study was conducted to test the new module provided by a peer and a psychiatrist via videoconferencing, termed tele-Indonesia Drug Addiction Relapse Prevention Program (tele-Indo-DARPP), with a pre- and postcontrolled design. We analyzed data from semistructured feedback interviews and outcome measurements, including the number of days using substances and quality of life, and compared the intervention (tele-Indo-DARPP added to treatment as usual [TAU]) and control (TAU only) arms.
RESULTS: In total, 8 people diagnosed with SUD participated in the pilot study with a mean age of 37 (SD 12.8) years. All were men, and 7 (88%) used sedatives as the primary substance. Collectively, they attended 44 of the 48 tele-Indo-DARPP sessions. A total of 3 out of 4 (75%) preferred telemedicine rather than in-person therapy. Positive acceptability and practicality were shown from qualitative feedback, in which the participants who joined the tele-Indo-DARPP reported that they liked the convenience of joining from home and that they were able to open up about personal matters, received helpful advice from peers, and received support from other participants. Providers reported that they feel the module was provider-friendly, and the session was convenient to join without diminishing rapport-building. Meanwhile, troubles with the internet connection and difficulty in comprehending some terminology in the workbook were reported. The intervention arm showed better improvements in psychological health and anxiety symptoms.
CONCLUSIONS: Group psychotherapy via videoconferencing coprovided by health care workers and peers was acceptable and practical for participants with SUD and service providers in this study. A large-scale study is warranted to examine the effectiveness of the newly developed module in Indonesia.
摘要：
背景：物质使用障碍（SUD）是印度尼西亚的主要健康问题，在治疗存在几个障碍的地方，包括无法获得治疗服务，污名,并将毒品问题定为犯罪。同伴参与和使用远程医疗提供心理治疗是克服这些障碍的有希望的方法。
目的：本研究旨在（1）描述由医护人员和同伴共同提供的新团体心理治疗的发展；（2）评估可接受性，实用性,以及该计划通过印度尼西亚的视频会议交付的初步成果。
方法：在日本建立的预防复发疗法的基础上，我们开发了一个为期3个月的每周一次的印尼语组治疗模块.通过与当地利益相关者就物质类型进行焦点小组讨论，进行了调整。可理解性,包容性语言，和文化相关性。进行了一项试点研究，以通过视频会议测试由同伴和精神科医生提供的新模块，称为远程印度尼西亚药物成瘾复发预防计划（tele-Indo-DARPP），与前和后控制的设计。我们分析了来自半结构化反馈访谈和结果测量的数据，包括使用物质的天数和生活质量，并比较了干预（tele-Indo-DARPP照常加入治疗[TAU]）和对照（仅TAU）组。
结果：总计，8名被诊断患有SUD的人参加了试点研究，平均年龄为37岁（SD12.8）。都是男人,和7（88％）使用镇静剂作为主要物质。总的来说，他们参加了48场远程-印度-DARPP会议中的44场。总共有四分之三（75％）的人首选远程医疗，而不是亲自治疗。从定性反馈中显示出积极的可接受性和实用性，其中加入tele-Indo-DARPP的参与者报告说，他们喜欢在家加入的便利，并且能够公开个人事务，收到了同行的有用建议，并得到了其他参与者的支持。提供商报告说，他们觉得该模块对提供商友好，会议很方便，可以在不削弱融洽关系的情况下加入。同时,据报道，互联网连接出现问题，难以理解工作簿中的一些术语。干预组的心理健康和焦虑症状得到了更好的改善。
结论：在这项研究中，通过由医护人员和同伴共同提供的视频会议进行的团体心理治疗对于SUD参与者和服务提供者来说是可以接受和实用的。有必要进行大规模研究，以检查印度尼西亚新开发的模块的有效性。
目的：本研究旨在（1）描述由医护人员和同伴共同提供的新团体心理治疗的发展；（2）评估可接受性，实用性,以及该计划通过印度尼西亚的视频会议交付的初步成果。
方法：在日本建立的预防复发疗法的基础上，我们开发了一个为期3个月的每周一次的印尼语组治疗模块.通过与当地利益相关者就物质类型进行焦点小组讨论，进行了调整。可理解性,包容性语言，和文化相关性。进行了一项试点研究，以通过视频会议测试由同伴和精神科医生提供的新模块，称为远程印度尼西亚药物成瘾复发预防计划（tele-Indo-DARPP），与前和后控制的设计。我们分析了来自半结构化反馈访谈和结果测量的数据，包括使用物质的天数和生活质量，并比较了干预（tele-Indo-DARPP照常加入治疗[TAU]）和对照（仅TAU）组。
结果：总计，8名被诊断患有SUD的人参加了试点研究，平均年龄为37岁（SD12.8）。都是男人,和7（88％）使用镇静剂作为主要物质。总的来说，他们参加了48场远程-印度-DARPP会议中的44场。总共有四分之三（75％）的人首选远程医疗，而不是亲自治疗。从定性反馈中显示出积极的可接受性和实用性，其中加入tele-Indo-DARPP的参与者报告说，他们喜欢在家加入的便利，并且能够公开个人事务，收到了同行的有用建议，并得到了其他参与者的支持。提供商报告说，他们觉得该模块对提供商友好，会议很方便，可以在不削弱融洽关系的情况下加入。同时,据报道，互联网连接出现问题，难以理解工作簿中的一些术语。干预组的心理健康和焦虑症状得到了更好的改善。
结论：在这项研究中，通过由医护人员和同伴共同提供的视频会议进行的团体心理治疗对于SUD参与者和服务提供者来说是可以接受和实用的。有必要进行大规模研究，以检查印度尼西亚新开发的模块的有效性。
